News

Categories

April 9, 2026

Zymeworks to Present at the AACR Oncology Industry Partnering Event

April 9, 2026

Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth

April 1, 2026

Zymeworks Appoints Kristin Stafford as Chief Financial Officer

March 30, 2026

Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate

March 24, 2026

Zymeworks Announces Participation in Upcoming Investor Conferences

March 18, 2026

Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting

March 17, 2026

Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting

March 2, 2026

Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing

March 2, 2026

Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results

February 12, 2026

Zymeworks To Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 2, 2026

January 27, 2026

Zymeworks Announces Participation in Upcoming Investor Conferences

January 12, 2026

Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy